Hereditary angioedema type 3 is extremely rare, and experts still cannot give a precise worldwide prevalence because many cases are hard to diagnose and the condition is now often grouped under “hereditary angioedema with normal C1 inhibitor.”
How rare it is
You should think of type 3 as a tiny subset of an already rare disease. Hereditary angioedema overall affects about 1 in 50,000 people worldwide, but type 3 is much less common and its exact share is not firmly established.
Why numbers are unclear
You do not get a clean prevalence estimate for type 3 because diagnosis is difficult and the condition has changed names over time. Earlier literature called it “type III,” while newer medical sources often use “HAE with normal C1 inhibitor,” which makes older case counts harder to compare directly.
What the evidence shows
Published medical reviews describe type 3 as rare enough that many reports are based on individual families or small case series rather than large population studies. One review notes that the prevalence has not been firmly established, which reflects how limited the data still are.
What this means for you
If you are asking because of symptoms, the key point is not just rarity but recognition: type 3 can cause recurrent swelling of the skin, abdomen, or airway, and it can be serious. Because the condition is uncommon and often missed, evaluation by a clinician familiar with hereditary angioedema matters.